| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.8 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |